ENTITY

Decoy Therapeutics (DCOY US)

3
Analysis
Health Care • United States
Decoy Therapeutics Inc. operates as a preclinical-stage biotechnology company. The Company specializes in drug development and manufacturing peptide conjugate therapeutics that focuses on respiratory viruses and GI cancers. Decoy Therapeutics serves customers in the United States.
more
Exchange Announcement • 08 Oct 2026 04:59

S-1 | IPO Registration

Exchange Announcement • 24 Sep 2026 05:02

Current Report (Form 8-K | Period ending 2026-09-22)

Exchange Announcement • 16 Sep 2026 05:00

Current Report (Form 8-K | Period ending 2026-09-14)

Exchange Announcement • 25 Feb 2026 22:15

Current Report (Form 8-K | Period ending 2026-02-24)

Exchange Announcement • 09 Jan 2026 01:38

Current Report (Form 8-K | Period ending 2026-01-08)

x